Celiprolol to prevent arterial events in patients with vascular Ehlers-Danlos and neither symptomatic nor silent arterial event. A retrospective cohort study from the French national reference center
Event:
ESC Congress 2022
Topic:
Pharmacotherapy
Session:
Medical management and risk factors